PAP Treatment and Sleep Education for Sleep Apnea
(RESTORE Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are using sedative-hypnotic medications above the recommended dose, you may not be eligible to participate.
What data supports the effectiveness of PAP Treatment and Sleep Education for Sleep Apnea?
Research shows that therapeutic patient education, which is part of the sleep education component, has been effective in improving quality of life and treatment adherence in conditions like asthma and atopic dermatitis. This suggests that similar educational approaches could help patients with sleep apnea better manage their condition.12345
Is PAP Treatment and Sleep Education safe for humans?
How is PAP Treatment and Sleep Education for Sleep Apnea different from other treatments?
This treatment is unique because it combines Continuous Positive Airway Pressure (CPAP) therapy, which uses a machine to help keep airways open during sleep, with a comprehensive sleep education program. The education component empowers patients to understand and manage their condition better, potentially improving adherence to CPAP therapy and overall quality of life.710111213
What is the purpose of this trial?
The purpose of this study is to look at how sleep disordered breathing (SDB) and not getting enough sleep each night contribute to daytime sleepiness. The investigators also want to determine the treatment that works best for improving daytime sleepiness.In this study, the investigators are comparing 2 programs that may improve symptoms of daytime sleepiness.
Research Team
M. Safwan Badr, MD, MBA
Principal Investigator
Wayne State University
Eligibility Criteria
This trial is for adults over 18 with mild to moderate sleep disordered breathing (SDB) and who often get less than 7 hours of sleep. They should feel sleepy during the day, but not be at high risk for falling asleep in dangerous situations like driving. People using certain sleep medications or treatments, those with severe health issues, substance use disorders, or other major sleep conditions can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive education about SDB and sleep, with one group receiving PAP devices, over four weekly sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments conducted immediately following the intervention and after 3 months
Treatment Details
Interventions
- PAP Treatment
- Sleep Education I
- Sleep Education II
PAP Treatment is already approved in European Union, United States, Canada, Japan for the following indications:
- Obstructive Sleep Apnea (OSA)
- Central Sleep Apnea (CSA)
- Sleep-Disordered Breathing (SDB)
- Obstructive Sleep Apnea (OSA)
- Central Sleep Apnea (CSA)
- Sleep-Disordered Breathing (SDB)
- Obstructive Sleep Apnea (OSA)
- Central Sleep Apnea (CSA)
- Sleep-Disordered Breathing (SDB)
- Obstructive Sleep Apnea (OSA)
- Central Sleep Apnea (CSA)
- Sleep-Disordered Breathing (SDB)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wayne State University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator